Stories
2021 Updates: Lilly's Global COVID-19 Response
View Story
Your COVID-19 Treatment Journey: Our Antibodies Might Help
View Story
2020 Updates: Lilly's Global COVID-19 Response
View Story
Digital Health: Partnering to Improve Outcomes
View Story
Naming a New Drug During a Pandemic
View Story
Lilly's COVID-19 Science Leads to a Second FDA Emergency Use Authorization
View Story
When the World Called for Help with COVID-19, We Were Ready
View Story
Dave Ricks Shares About Lilly's FDA Emergency Use Authorization for a Neutralizing Antibody
View Story
CEO Dave Ricks Shares Lilly's Principles of COVID-19 Antibody Therapy Pricing and Access
View Story
Increasing Diversity in Clinical Trials
View Story